Related Experiment Video
Updated: May 5, 2026
09:33
Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
Published on: March 20, 2026
120
Neuro-Oncology Biotech Industry Progress Report 2025
Zoey A Croft1, Griffin Thomas1, Evan Keister1
1Neurosurgery, Lenox Hill Hospital, New York, USA.
Cureus
|May 4, 2026
Summary
The 2025 Brain Tumor Biotech Summit showcased advancements in neuro-oncology, focusing on new treatments and drug delivery for brain tumors. Translational partnerships are crucial for accelerating therapy development for glioma patients.
Area of Science:
- Neuro-oncology
- Cancer Therapeutics
- Biotechnology
Background:
- Neuro-oncology is a rapidly advancing field with increasing clinical trials.
- The 2025 Brain Tumor Biotech Summit convened leaders from academia, biotech, and investment.
Purpose of the Study:
- To summarize key discussions and advancements presented at the 2025 Brain Tumor Biotech Summit.
- To highlight emerging treatments, novel drug delivery, and device-based therapeutics in neuro-oncology.
Main Methods:
- The summit focused on progress in clinical trials for glioblastoma (GBM) and other CNS tumors.
- Presentations covered early-phase technologies and personalized treatment strategies.
Main Results:
- Recent advancements in neuro-oncology were discussed.
- Progress on clinical trials and early-phase technologies for brain tumors was presented.
Conclusions:
- Translational partnerships are vital for accelerating therapy development.
- The summit emphasized the importance of collaboration in advancing treatments for glioma patients.
More Related Videos
Related Concept Videos
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
02:07Tumor Progression
3.1K
3.1K
02:57Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
02:57Targeted Cancer Therapies
1.4K
1.4K
02:56Treatment Resistant Cancers
2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
02:56Treatment Resistent Cancers
1.1K
1.1K